Google+ Facebook Twitter Twitter

Tech news: April

This month's top tech news stories

Menarini Diagnostics
Eye control system for digital dissection

Menarini Diagnostics, one of the UK’s leading suppliers of diagnostic equipment, is expanding its comprehensive cellular pathology portfolio with LOOX eye control system for the MacroPATH digital imaging system range.

It is a completely unique solution that allows the biomedical scientist and pathologist to zoom in and out, take images, videos and audio hands-free, only using their eye movements. This new way of working will therefore minimise contamination at the specimens cut up station. LOOX will additionally increase productivity with providing a more intuitive and engaging hands-free user interaction.

LOOX will replace the mouse, keyboard or foot pedal and can be used with glasses, contact lenses or face shields. LOOX is compatible with the MacroPATH imaging system range (MacroPATH, eGROSS and WorkSTATION) so it can be installed on existing customer systems or for any new installations.


Veolia Water Technologies
Purified water

Veolia Water Technologies UK’s PURELAB Quest unit has been selected to provide a complete purified water solution for a newly refurbished laboratory at University College London (UCL). The unit delivers all required types of purified water and was chosen to maximise workspace. Located on the main UCL campus, the Anatomy Building has been undergoing phased updates to much of its interior, including several separate lab areas.



Related Articles

Tech news: October

This month's top tech news stories

Under the microscope: chronic allograft dysfunction

What is chronic allograft dysfunction (CLAD)?

A range of pathologies that cause a transplanted lung to not achieve or maintain normal function. CLAD manifests as airflow restriction or obstruction.

Evolutionary changes in brain development

More than 3000 regions in the human genome are very different to those in the genome of any other mammals, including our closest primate relatives.

Turning normal cells into cancer cells

There is new evidence that normal human fibroblast cells can be converted to specific cancer cells using only factors that are commonly detected in actual human patients.